ASHLEY MCGINNIS: Open Payments
NPI 1750629432 · SLIDELL, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,601 in 76 payments from 19 companies in 2025. Trend: 2023 $1,402 · 2024 $2,028 · 2025 $1,601
Food & beverage: $1,601
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $247 |
| Stryker Corporation | 2 | $217 |
| GlaxoSmithKline, LLC. | 12 | $164 |
| ABBVIE INC. | 13 | $156 |
| Novo Nordisk Inc | 11 | $150 |
| Lilly USA, LLC | 8 | $127 |
| PFIZER INC. | 7 | $127 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $83 |
| Otsuka America Pharmaceutical, Inc. | 4 | $69 |
| Axsome Therapeutics, Inc. | 2 | $54 |
Products named: BREZTRI, FLOWTRIEVER, MOUNJARO, VRAYLAR, ELIQUIS, SHINGRIX, Ozempic, Kerendia.
Industry payments across LA — which companies pay providers there.
